Format

Send to

Choose Destination
J Anesth. 2019 Jan 17. doi: 10.1007/s00540-019-02612-w. [Epub ahead of print]

Low-dose dexmedetomidine provides hemodynamics stabilization during emergence and recovery from general anesthesia in patients undergoing carotid endarterectomy: a randomized double-blind, placebo-controlled trial.

Author information

1
Department of Anesthesiology, Yao Tokushukai General Hospital, 1-17, Wakakusamachi, Yao City, Osaka, 581-0011, Japan. seashogo@shirt.ocn.ne.jp.
2
Department of Anesthesiology, Yao Tokushukai General Hospital, 1-17, Wakakusamachi, Yao City, Osaka, 581-0011, Japan.

Abstract

PURPOSE:

Carotid artery stenosis is a major risk factor for ischemic stroke. Carotid endarterectomy protects patients with severe atherosclerotic carotid artery stenosis against stroke. In such patients, arterial blood pressure is often difficult to control and perioperative hemodynamic instability is associated with high morbidity and mortality after carotid endarterectomy. We performed a randomized double-blind placebo-control trial to evaluate the effects of low-dose dexmedetomidine on hemodynamic stability during the emergence and the recovery phases of general anesthesia in patients undergoing carotid endarterectomy.

METHODS:

Forty-seven patients (68-84 years) were randomly assigned to receive either dexmedetomidine (DEX group) or 0.9% saline (control group). Infusion of dexmedetomidine 1.0 µg/kg/hr for 1 h, followed by 0.2 µg/kg/hr or the same dose of saline was started after carotid artery declamping in the DEX and in the control group, respectively. At the end of surgery, nicardipine was used to maintain systolic arterial pressure within 20% of preoperative values. We compared the maximum dose of nicardipine, time to extubation, plasma catecholamine levels, arterial blood gases, the Richmond Agitation Sedation Scales, visual analogue scale (VAS) in the postanesthesia care unit, and adverse events within 30-days between the control and Dex groups.

RESULTS:

The baseline clinical characteristics were similar in the two groups. The maximum dose of nicardipine (p = 0.021), plasma norepinephrine level (p = 0.033), sedation score and VAS were significantly lower in the Dex group than the control group. There were no differences between the two groups regarding time to extubation, arterial blood gases, and adverse events.

CONCLUSIONS:

Low-dose dexmedetomidine improves hemodynamic stability during emergence and recovery from general anesthesia in patients receiving carotid endarterectomy.

TRIAL REGISTRY NUMBER:

UMIN000010607.

KEYWORDS:

Carotid endarterectomy; Dexmedetomidine; Hemodynamics

PMID:
30656404
DOI:
10.1007/s00540-019-02612-w

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center